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Abstract
Mutations of SLC26A4 are a common cause of human hearing loss associated with enlargement of the vestibular aqueduct.
SLC26A4 encodes pendrin, an anion exchanger expressed in a variety of epithelial cells in the cochlea, the vestibular
labyrinth and the endolymphatic sac. Slc26a4D/D mice are devoid of pendrin and develop a severe enlargement of the
membranous labyrinth, fail to acquire hearing and balance, and thereby provide a model for the human phenotype. Here,
we generated a transgenic mouse line that expresses human SLC26A4 controlled by the promoter of ATP6V1B1. Crossing
this transgene into the Slc26a4D/D line restored protein expression of pendrin in the endolymphatic sac without inducing
detectable expression in the cochlea or the vestibular sensory organs. The transgene prevented abnormal enlargement of
the membranous labyrinth, restored a normal endocochlear potential, normal pH gradients between endolymph and
perilymph in the cochlea, normal otoconia formation in the vestibular labyrinth and normal sensory functions of hearing
and balance. Our study demonstrates that restoration of pendrin to the endolymphatic sac is sufficient to restore normal
inner ear function. This finding in conjunction with our previous report that pendrin expression is required for embryonic
development but not for the maintenance of hearing opens the prospect that a spatially and temporally limited therapy will
restore normal hearing in human patients carrying a variety of mutations of SLC26A4.
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Introduction
Enlargement of the vestibular aqueduct (EVA; OMIM
#600791) is a malformation of the temporal bone that is
commonly observed in children with sensorineural hearing loss
[1,2,3,4,5]. Mutations of SLC26A4 are the most common cause for
EVA-associated hearing loss that can either be non-syndromic
(DFNB4; OMIM # 600791) or syndromic with enlargement of the
thyroid gland (Pendred syndrome; OMIM #274600). SLC26A4
codes for the anion exchanger pendrin that transports anions such
as Cl2, I2 and HCO3
2 [6,7]. Although EVA is a malformation of
the temporal bone, it is not the cause for hearing loss since no
correlation was found between the degree of EVA and the severity
of hearing impairment [8]. EVA, however, is an indication of an
enlargement of the endolymphatic duct epithelium that was
present during embryonic development. Cartilage cells that form
in the periphery of the endolymphatic duct epithelium preserve
the diameter of the duct in a ‘fossil-like’ record when they give rise
to the bone of the vestibular aqueduct.
The mature inner ear consists of seven interconnected fluid
spaces that house six sensory organs (Fig. 1): The cochlea for
hearing, the utricle and saccule for sensing linear acceleration
including gravity, and three ampullae with semicircular canals for
sensing angular acceleration in three spatial axes. The seventh
fluid compartment is the endolymphatic duct and sac, which is
devoid of sensory cells and which is suspected to play a role in fluid
homeostasis [9,10]. Pendrin is expressed in a variety of epithelial
cells that enclose endolymph, which is the luminal fluid of the
inner ear (Fig. 1). Pendrin is expressed in outer sulcus, spiral
prominence and spindle-shaped cells in the cochlea, transitional
cells in the utricle, saccule and ampullae and mitochondria-rich
cells (synonym: Forkhead-related or FORE cells) of the endolym-
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phatic sac [11,12]. Each cell type represents a small domain in the
heterogeneous epithelium that encloses endolymph. The many
locations and cell types that express pendrin in a normal inner ear
made the goal to restore function through restoration of expression
look futile unless some sites of expression were more important
than others.
The earliest onset of pendrin expression in the murine inner ear
occurs in the endolymphatic sac at embryonic day E11.5, which
precedes the onset of expression in the cochlea by 3 days, in the
saccule and utricle by 4 days, and in the ampullae by 5 days [13].
The expression in the endolymphatic sac surges dramatically at
E14.5, a time in development when there is very little pendrin
expressed elsewhere in the inner ear [13].
Studies in a mouse model, Slc26a4D/D, have revealed that loss of
pendrin leads to an enlargement of endolymph volume followed
by an acidification and a failure to develop normal hearing and
balance [13,14]. The onset of the enlargement in the cochlea and
the endolymphatic sac occurs at E14.5 which precedes the onset of
the luminal acidification by 1 day in the cochlea and by 3 days in
the endolymphatic sac [13]. The enlargement develops in
Slc26a4D/D mice between E14.5 and E18.5, which is the phase
of rapid growth of the cochlea [4]. The coincidence of the surge in
pendrin expression in the endolymphatic sac at E14.5 and the
onset of the enlargement in Slc26a4D/D mice points to the
importance of pendrin expression in the endolymphatic sac for
inner ear fluid homeostasis.
We hypothesized that restoration of pendrin expression in the
endolymphatic sac would prevent enlargement and permit normal
development of the cochlea and the vestibular labyrinth including
the acquisition of sensory function. To test this hypothesis, we
generated a mouse line that expresses human pendrin SLC26A4
controlled by the promoter of the B1-subunit of the human
vacuolar H+ ATPase (ATP6V1B1) and crossed this transgene into
Figure 1. Schematic diagram of the inner ear. A) Diagram of the membranous labyrinth. The two continuous luminal fluid spaces of the mature
inner ear are filled with endolymph (pink and purple). B–E) Diagrams of a cross section of one cochlear turn (B), of the utricle or saccule (C), of one
ampulla (D) and the endolymphatic sac (E). Cells that express pendrin (yellow cells pointed to by arrows) are diagrammed in mature tissues.
doi:10.1371/journal.pgen.1003641.g001
Author Summary
Mutations of SLC26A4 are the most common cause for
hearing loss associated with a swelling of the inner ear.
This human disease is largely recapitulated in a mutant
mouse model. Mutant mice lack Slc26a4 expression and
their inner ears swell during embryonic development,
which leads to failure of the cochlea and the vestibular
organs resulting in deafness and loss of balance. SLC26A4
is normally found in the cochlea and vestibular organs of
the inner ear as well as in the endolymphatic sac, which is
a non-sensory part of the inner ear. The multitude of sites
where SLC26A4 is located made the goal to restore
function through restoration look futile, unless some sites
were more important than others. Here, we generated a
new mutant mouse that expresses SLC26A4 in the
endolymphatic sac but not in the cochlea or the vestibular
organs of the inner ear. Fantastically, this mouse did not
develop the detrimental swelling of the inner ear and even
more exciting, the mouse developed normal hearing and
balance. Our study provides the proof-of-concept that a
therapy aimed at repairing the endolymphatic sac during
embryonic development is sufficient to restore a life-time
of normal hearing and balance.
Rescue of Hearing & Balance in Slc26a4 Mutant Mice
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the Slc26a4D/D line to generate mice that lack expression of mouse
pendrin but express human pendrin in the endolymphatic sac. No
expression of pendrin protein was detected in these mice in the
cochlea or the vestibular labyrinth but in mitochondria-rich cells
of the endolymphatic sac. Analysis of this mouse model revealed
normal hearing and balance function. Our data indicate that the
expression of pendrin solely in the endolymphatic sac of the inner
ear is sufficient to permit the development of normal hearing and
balance.
Results
Generation of Tg(+);Slc26a4D/D transgenic mice
A transgenic mouse line, referred to as Tg(B1-hPDS)Tg/+;
Slc26a4+/+ and abbreviated here to Tg(+);Slc26a4+/+, was created
by the laboratory of Dr. Dominique Eladari (Paris, France) [15].
This mouse expresses human SLC26A4 (formerly named hPDS)
controlled by the promoter of ATP6V1B1, which codes for the B1-
subunit of the vH+ATPase. Transgenic founders were crossed with
wild-type C57BL/66 CBA F1 mice and three Tg(+);Slc26a4+/+
mice were shipped to Kansas State University (Manhattan,
Kansas, USA). At Kansas State University, Tg(+);Slc26a4+/+ mice
were crossed with Slc26a4D/D mice, which are maintained in an
isogenic 129S6SvEv background, to generate the desired
Tg(+);Slc26a4D/D mice in an F2 generation. Expression of
SLC26A4 (human pendrin) in this mouse was expected to originate
solely from the transgene since Exon 8 in the Slc26a4D allele was
replaced with a neomycin-cassette that introduced a frame-shift
[14]. Littermates with the genotype Tg(2);Slc26a4D/D served as
negative controls. These mice were expected to lack functional
pendrin protein expression. Further, littermates with genotypes
Tg(2);Slc26a4D/+, Tg(+);Slc26a4D/+, and Tg(+);Slc26a4+/+ served
as positive controls. These mice were expected to express murine
pendrin with or without augmentation of human pendrin and
have normal hearing and balance.
mRNA expression
Expression of Atp1a1, Atp6v1b1, Slc26a4 and SLC26A4 was
determined by quantitative RT-PCR and normalized to the
expression of 18S rRNA (Fig. 2). The highest levels of Atp6v1b1
and Slc26a4 mRNA among the different inner ear tissues were
found in the endolymphatic sac (Fig. 2B and C). Expression of
Slc26a4 was reduced by factors between 6 and 16 in
Tg(+);Slc26a4D/D mice compared to Tg(2);Slc26a4D/+ mice
(Fig. 2C vs G). Expression levels of Atp1a1 and Atp6v1b1 exhibited
a similar pattern among inner ear tissues of Tg(2);Slc26a4D/+ and
Tg(+);Slc26a4D/D mice (Fig. 2A vs E and Fig. 2B vs F). Most
interesting, expression levels of human SLC26A4 in
Tg(+);Slc26a4D/D resembled the pattern of mouse Slc26a4 in
Tg(2);Slc26a4D/+ mice with the highest levels being expressed in
the endolymphatic sac (Fig. 2C vs H). Whether or not expression
levels of human SLC26A4 in Tg(+);Slc26a4D/D exceeded expression
levels of mouse Slc26a4 in Tg(2);Slc26a4D/+ mice remained
undetermined, since the efficiency of the reverse transcription of
Figure 2. Atp1a1, Atp6v1b1, Slc26a4, and SLC26A4 mRNA levels in inner ear tissues. Expression was determined by quantitative RT-PCR
performed on total RNA. Total RNA was isolated from microdissected tissues obtained from Tg(2);Slc26a4D/+ (A–D) and Tg(+);Slc26a4D/D mice (E–H).
Endolymphatic sacs (ES) were isolated from mice at age E17.5. Cochleae were isolated at ages E17.5 (C1) and P2 (C2). Vestibular labyrinths (VL),
consisted of saccule, utricle, ampullae and semicircular canals without endolymphatic sacs, were isolated at age P8. The expression of endogenous
mouse Atp1a1, Atp6v1b1, and Slc26a4, and of transgenic human SLC26A4 mRNA was normalized to the expression of 18S rRNA. Note that the
expression pattern of human SLC26A4 in Tg(+);Slc26a4D/D mice resembles the pattern of mouse Slc26a4 in Tg(2);Slc26a4D/+ mice (both patterns
highlighted in red). Numbers inside graphs represent the number of experiments.
doi:10.1371/journal.pgen.1003641.g002
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mRNA into cDNA remains generally unknown in quantitative
RT-PCR experiments. Taken together, the data demonstrate that
the transgene restored pendrin mRNA expression to the endo-
lymphatic sac, the cochlea and the vestibular labyrinth of the inner
ear.
Protein expression - eGFP expression
The ability of the ATP6V1B1 promoter to drive protein
expression in different tissues including the cochlea, the vestibular
labyrinth and the endolymphatic sac was evaluated in a transgenic
mouse line, Tg(B1-eGFP) in which the expression of eGFP is
controlled by the same 6.9 kb promoter of the human ATP6V1B1
gene that drives the expression of human pendrin in
Tg(+);Slc26a4D/D mice [16]. No expression of eGFP was detected
in the cochlea or the vestibular labyrinth of E15.5 Tg(B1-eGFP)
mice, although expression was present in the endolymphatic sac
and the kidney (Fig. 3). These data suggest that the ATP6V1B1
promoter does not drive protein expression in the cochlea or the
vestibular labyrinth.
Protein expression - Western blotting
Soft tissues of the cochlea and the vestibular labyrinth, exclusive
of the endolymph sac, were collected from adult mice by
microdissection and pooled into an ‘inner ear’ sample. Crude
membrane protein preparations were obtained from these inner
ear samples and from kidneys and subjected to gel-electrophoresis
and Western blotting. Membrane proteins were obtained from
Tg(+);Slc26a4D/D mice as well as from Tg(2);Slc26a4D/+ mice,
which served as positive controls, and from Tg(2);Slc26a4D/D
mice, which served as negative controls. Pendrin was detected in
the inner ear and kidney of Tg(2);Slc26a4D/+ mice as a ,110 kDa
band (Fig. 4A). Inner ear from Tg(+);Slc26a4D/D mice lacked this
band. The observation that there was no difference in the pattern
of faint bands between inner ears from Tg(+);Slc26a4D/D mice and
Tg(2);Slc26a4D/D mice, which is the negative control, suggests that
pendrin was either not detectable or not present. The pendrin
band, however, was found in kidney from Tg(+);Slc26a4D/D mice
(Fig. 4B), which suggests that the antibody recognizes both mouse
and human pendrin. The observation that pendrin was detected at
Figure 3. Transgene-encoded eGFP expression. A–C) Expression of eGFP was monitored as direct fluorescence in cochlear ducts (A),
endolymphatic sacs (B), and kidney slices (C) freshly isolated from E15.5 Tg(B1-eGFP) mice. The outline of the imaged tissues is marked (dashed-line).
D–I) Expression of eGFP was evaluated by immunocytochemistry in the cochlea (D), utricle (E), ampulla (F), endolymphatic sac (G), kidney cortex (H),
and kidney medulla (I) from E15.5 Tg(B1-eGFP) mice. Staining consisted of immunocytochemistry of eGFP (green), F-actin (red) and nucleic acids (blue).
The number of mice represented by these images are 2 for images A–C and 2 for images D–I. MR, mitochondria-rich cells; IC, intercalated cells; Lim,
spiral limbus; K, Ko¨lliker’s organ; OS, outer sulcus; SV, stria vascularis; HC, vestibular hair cells; TC, transitional cells; M, melanocytes.
doi:10.1371/journal.pgen.1003641.g003
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similar levels in descending amounts of kidney proteins isolated
from Tg(2);Slc26a4D/+ mice (Fig. 4A) and Tg(+);Slc26a4D/D mice
(Fig. 4C) suggests that the detection threshold for mouse and
human pendrin was similar. Whether the antibody differed in the
sensitivity between mouse and human pendrin remains unknown,
since the relative abundance of mouse pendrin in kidneys of
Tg(2);Slc26a4D/+ mice and human pendrin in kidneys of
Tg(+);Slc26a4D/D mice is not known.
The meaning of pendrin being not detectable in the inner ear
was evaluated by comparison of the intensity of the pendrin band
in inner ear to the intensities in descending amounts of kidney
protein (Fig. 4A). This comparison suggests that a ,5-fold lower
amount pendrin should have been detectable in the inner ear. This
means that pendrin expression in the inner ear of Tg(+);Slc26a4D/D
mice is either absent or expressed at a level that does not exceed
20% of the expression level in Tg(2);Slc26a4D/+ mice.
Paint-fill of the cochlea and the endolymphatic sac
Temporal bones from Tg(+);Slc26a4D/+ and Tg(+);Slc26a4D/D
mice were isolated at E15.5, fixed and injected with white paint
(Fig. 5A and B). Most striking is that there was no enlargement of
the endolymphatic sac, duct or cochlea in Tg(+);Slc26a4D/D mice
and that the morphology of Tg(+);Slc26a4D/+ and Tg(+);Slc26a4D/D
mice was grossly similar. These data demonstrate that the
introduction of the transgene rescued the malformation previously
described in Slc26a4D/D mice [10,14].
Figure 4. Pendrin expression evaluated by Western blotting. Proteins in crude membranes prepared from pooled inner ear tissues consisting
of soft tissues from the cochlea and the vestibular labyrinth devoid of endolymphatic sac and crude membranes prepared from kidneys of
Tg(2)Slc26a4D/+, Tg(2)Slc26a4D/D and Tg(+)Slc26a4D/D mice were resolved by gel-electrophoresis and detected with an anti-pendrin antibody (Pds
#1) and an anti-b-actin antibody. b-actin served as a loading control. A) Comparison of pendrin expression in membranes prepared from inner ears
of Tg(2)Slc26a4D/+, Tg(2)Slc26a4D/D and Tg(+)Slc26a4D/D mice to expression levels in descending amounts of membranes prepared from kidneys of
Tg(2)Slc26a4D/+ mice. B) Comparison of pendrin expression in membranes prepared from kidneys of Tg(2)Slc26a4D/+, Tg(2)Slc26a4D/D and
Tg(+)Slc26a4D/D mice. C) Expression levels of pendrin in descending amounts of membranes prepared from kidneys of Tg(+)Slc26a4D/D mice. Data
shown in A, B and C are each representative of 2 biological replicates.
doi:10.1371/journal.pgen.1003641.g004
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Histology and pendrin expression in the endolymphatic
sac
Whole-mounted specimens of the endolymphatic sac were
prepared for immunocytochemistry from Tg(+);Slc26a4D/D,
Tg(2);Slc26a4D/D, and Tg(+);Slc26a4D/+ mice (Fig. 5C–E). Most
striking is the enlargement and lack of pendrin expression in the
endolymphatic sac of Tg(2);Slc26a4D/D mice (Fig. 5E) and the
similarity in size and similarity in pendrin expression between the
endolymphatic sac of Tg(+);Slc26a4D/D mice (Fig. 5C) and
Tg(+);Slc26a4D/+ mice (Fig. 5D). These data demonstrate that
the transgene drives pendrin expression in the endolymphatic sac
and that the introduction of the transgene rescued the malforma-
tion [10,14].
Gross morphology of the cochlea
Gross morphological examination of inner ears revealed greater
similarity between Tg(+);Slc26a4D/D mice and Tg(+);Slc26a4D/+
than between Tg(+);Slc26a4D/D mice and Tg(2);Slc26a4D/D mice
(Fig. 6A–C). Cochlear turns in Tg(+);Slc26a4D/D mice appeared
normal in width and did not show widening of turns or thinning of
the otic capsule that was seen in Tg(2);Slc26a4D/D and that was
previously described in Slc26a4D/D mice [12,17]. Inspection of the
oval window revealed ‘glittering’ otoconia in the saccule in
Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice in contrast to
Tg(2);Slc26a4D/D mice where no ‘glittering’ was visible (Fig. 6D–
F).
Histology and pendrin expression in the cochlea
Midmodiolar sections of cochlear tissues were prepared for
immunocytochemistry from Tg(+);Slc26a4D/D mice and positive
controls consisting of Tg(2);Slc26a4D/+ or Tg(+);Slc26a4D/+ mice.
No evidence for cochlear enlargement was found in
Tg(+);Slc26a4D/D mice at E16.5 (Fig. 7B), P1 (Fig. S1A), P16
(Fig. 7A; Fig. S1E) or P18 (Fig. S1C) suggesting that the
introduction of the transgene rescued the cochlear malformation
previously described in Slc26a4D/D mice, which includes a ,10-
fold enlargement of the cochlea [12,14]. No detectable pendrin
expression was found in the spiral prominence or outer sulcus
epithelium of the cochlea in Tg(+);Slc26a4D/D mice although
prominent expression was observed in these cells in positive
controls (Fig. 7 and S1). The absence of pendrin in Tg(+);
Slc26a4D/D mice was observed with two different anti-pendrin
antibodies (Pds #1 and Pds #2). The patterns of pendrin
expression in the positive controls, Tg(2);Slc26a4D/+ and
Tg(+);Slc26a4D/+ mice, were similar for both antibodies to the
pattern previously observed in Slc26a4D/+ mice [11,12,13].
Expression of pendrin was further examined in whole-mounted
Figure 5. Histology and pendrin expression in the embryonic endolymphatic sac. A–B) Paint filled inner ears from Tg(+);Slc26a4D/D and
Tg(+);Slc26a4D/+ mice at age E15.5. Note that neither the endolymphatic duct (E. duct) nor the endolymphatic sac (E. sac) were enlarged. C–E) Pendrin
protein expression in the endolymphatic sac at age E16.5. Staining consisted of immunocytochemistry of pendrin (red) and F-actin (green). Images
provide comparison of whole mounts from Tg(+);Slc26a4D/D mice (C), Tg(+);Slc26a4D/+ mice (D), and Tg(2);Slc26a4D/D mice (E). Note that images C–E
are presented at the same scale. The number of mice represented by these images is 2 for A, 2 for B, 3 for C, 4 for D, and 1 for E. MR, mitochondria-
rich cells.
doi:10.1371/journal.pgen.1003641.g005
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specimens that encompassed the spiral limbus, organ of Corti and
outer sulcus. No detectable pendrin expression was found at age
P35 in the spiral limbus of Tg(+);Slc26a4D/D mice (Fig. 7C) or
Tg(2);Slc26a4D/+ mice (Fig. 7H) in contrast to the prominent
expression of pendrin in the outer sulcus epithelia of
Tg(2);Slc26a4D/+ mice (Fig. 7J). For completeness, it needs to be
reported that some punctate staining was found in nerve terminals
near inner hair cells of Tg(+);Slc26a4D/D (Fig. 7D) and
Tg(2);Slc26a4D/+ mice (Fig. 7I).
Endocochlear potential and pH
The endocochlear potential and the difference in pH between
endolymph and perilymph was measured with double-barreled ion
selective electrodes in Tg(2);Slc26a4D/D mice, Tg(+);Slc26a4D/+
mice, and Tg(+);Slc26a4D/D mice (Fig. 8). Tg(2);Slc26a4D/D mice
failed to develop a normal endocochlear potential and the pH of
endolymph was lower ( =more acidic) than in perilymph, as
previously reported [18]. In contrast, Tg(+);Slc26a4D/+ mice, as
reported for Slc26a4D/+mice [18], developed a normal endocochlear
potential and a normal endolymphatic pH that was higher ( =more
alkaline) than in perilymph. Similar to Tg(+);Slc26a4D/+ mice,
Tg(+);Slc26a4D/D mice developed a normal endocochlear potential
and a normal endolymphatic pH even though no detectable pendrin
expression was observed in the cochlear epithelium. These data
demonstrate that the introduction of the transgene, which rescued
the malformation, also rescued the loss of the endocochlear potential
and the loss of normal endolymphatic pH homeostasis.
Hearing
Hearing tests were based on auditory brain stem recordings and
thresholds in response to tone bursts of 8 kHz, 16 kHz and
32 kHz. Tests performed in Tg(+);Slc26a4+/+, Tg(2);Slc26a4D/D
and Tg(+);Slc26a4D/D mice confirmed profound deafness in
Tg(2);Slc26a4D/D mice (Fig. 9B) consistent with previous findings
in Slc26a4D/D mice [14,18]. Waveforms of auditory brain stem
recordings as well as thresholds were similar between
Tg(+);Slc26a4D/D mice (Fig. 9A) and Tg(+);Slc26a4D/+ (Fig. 9C).
These findings demonstrate that the introduction of the transgene
rescued normal hearing although the cochlea did not express
detectable levels of pendrin. We next evaluated whether the
rescued hearing phenotype in Tg(+);Slc26a4D/D would be stable
through at least 3 months of age. Auditory brain stem recordings
were performed in Tg(+);Slc26a4D/+ mice (Fig. 9D–F), in
Tg(+);Slc26a4D/D mice (Fig. 9J–L), and in Tg(+);Slc26a4+/+ mice
(Fig. 9G–I) at 1, 2 and 3 month of age. Hearing in Tg(+);Slc26a4D/D
mice at 8 kHz and 16 kHz was stable through 3 months.
Figure 6. Gross morphology of the cochlea isolated by microdissection. A–C) Overview images of cochleae from a Tg(2);Slc26a4D/D,
Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice. The width of the lower cochlear turn is marked with arrows and the round (RW) and oval window (OW)
are labeled. A region with apparently thinner bone is marked (*). D–F) Enlarged view of the oval window. Normal otoconia in the saccule that reflect
the light and appear bright white were seen in Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice but not in Tg(2);Slc26a4D/D (arrow). The number of mice
represented by these images is 1 for A and D, and 3 pairs for images B & C and E & F.
doi:10.1371/journal.pgen.1003641.g006
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Figure 7. Histology and pendrin expression in the cochlea. Staining in all images consisted of immunocytochemistry of pendrin (Pds #1
antibody; red), F-actin (green) and nucleic acids (blue). Images provide comparison of cryosections (A–B) and whole-mounted specimens (C–E) from
Tg(+);Slc26a4D/D mice to cryosections (F–G) and whole-mounted specimens (H–J) from Tg(2);Slc26a4D/+ mice. Whole-mounted specimens in C, E, H
and J were imaged by detecting fluorescence in 25 optical sections that were recorded in 1 mm intervals and projected into a single plane. Whole-
mounted specimens in D and I were imaged by detecting fluorescence in 8 optical sections that were recorded in 1 mm intervals, projected into a
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Thresholds were very similar among individuals and did not differ
from Tg(+);Slc26a4D/+ and Tg(+);Slc26a4+/+ mice. A greater
variability in hearing thresholds was observed at 32 kHz (Fig. 9L),
with 10 of the 19 Tg(+);Slc26a4D/D mice maintaining excellent
hearing (thresholds #30 dB at 32 kHz) and 5 developing a high-
frequency hearing loss (thresholds $60 dB at 32 kHz). About one
half of the Tg(+);Slc26a4D/D mice (9 of 19) developed progressive
threshold elevations at 32 kHz with thresholds increasing by
$10 dB between the monthly measurements. This variability is
reflected in the greater error bars at 32 kHz but did not lead to a
statistically significant difference between Tg(+);Slc26a4D/D and
Tg(+);Slc26a4+/+ mice.
Histology and pendrin expression in the vestibular
labyrinth
Sections and whole-mounted specimens of vestibular tissues
were prepared for immunocytochemistry from Tg(+);Slc26a4D/D
mice and positive controls consisting of Tg(2);Slc26a4D/+ or
Tg(+);Slc26a4D/+ mice. No evidence of pendrin expression was
found in the three sensory organs in Tg(+);Slc26a4D/D mice at P14
(Fig. S2A), P16 (Fig. 10A,C,D and Fig. S2C,G,K), P18 (S2E), and
P35 (Fig. 10B). The absence of pendrin in Tg(+);Slc26a4D/D mice
was observed with two different anti-pendrin antibodies (Pds #1
and Pds #2). In contrast, pendrin expression was found in
transitional cells of the utricle, saccule and ampullae of controls
that consisted of Tg(2);Slc26a4D/+ or Tg(+);Slc26a4D/+ mice. The
expression patterns in Tg(2);Slc26a4D/+ and Tg(+);Slc26a4D/+
mice with both antibodies were similar to the pattern previously
described in Slc26a4D/+ mice [11,12].
Otoconia
Vestibular labyrinths were isolated by microdissection from
Tg(2);Slc26a4D/D, Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice
and the roof of the utricle was removed to permit an unobstructed
view onto the utricular macula (Fig. 11A–C). Glittering otoconia
were observed in Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice and
giant otoconia in Tg(2);Slc26a4D/D. Otoconia were transferred
into glass-bottom dishes and inspected by laser-scanning micros-
copy using a 405 nm laser. Giant otoconia from Tg(2);Slc26a4D/D
mice were ,10-fold larger than normal otoconia (Fig. 11D). The
shape of the giant otoconia resembled the shape previously
observed in Slc26a4D/D mice [12]. Otoconia in Tg(+);Slc26a4D/D
and Tg(+);Slc26a4D/+ mice were similar consisting in both
genotypes of larger (,20 mm, Figs. 11E.1 and F.1) and smaller
(,10 mm; Figs. 11E.2 and F.2) otoconia, some of which revealed a
concentric structure (Figs. 11E.3 and F.3). These data suggest that
the introduction of the transgene rescued normal otoconia
formation.
Balance
Balance tests were performed in Tg(+);Slc26a4D/D mice and
Tg(+);Slc26a4D/+ mice as well as in Tg(2);Slc26a4D/+ and
Tg(2);Slc26a4D/D mice (Fig. 12). Tg(2);Slc26a4D/D mice failed
the test, which confirmed the vestibular phenotype previously
described in Slc26a4D/D mice [14]. There was no apparent
difference in the performance of Tg(+);Slc26a4D/D, Tg(+);
Slc26a4D/+ and Tg(2);Slc26a4D/+ mice. These data demonstrate
that the introduction of the transgene rescued normal gross motor
vestibular function.
Discussion
In this study we generated a mouse that expresses human
pendrin in the endolymphatic sac but lacks detectable pendrin
protein expression in the cochlea or in the vestibular labyrinth.
The most biologically interesting and clinically relevant observa-
tion of this study is that this mouse develops normal hearing and
balance. Our findings support the hypothesis that pendrin
expression in the endolymphatic sac is chiefly responsible for the
development of normal endolymph volume, that lack of pendrin in
the endolymphatic sac is mainly responsible for the development
single plane and overlaid onto a single brightfield image. The number of pairs of mice represented by these images are 2 for image A & F, 3 for B &
G, and 1 for C–E & H–J with 3 sections being evaluated per animal. K, Ko¨lliker’s organ; OS, outer sulcus; Lim, spiral limbus; IS, inner sulcus; OC, organ
of Corti; SP, spiral prominence; SV, stria vascularis; RM, Reissner’s membrane. Additional images using an alternative anti-pendrin antibody (Pds #2)
and alternative positive controls (Tg(+);Slc26a4D/+ mice) are provided in the Supplement (Fig. S1).
doi:10.1371/journal.pgen.1003641.g007
Figure 8. Endocochlear potential and pH. Endocochlear potential (A) and the difference between endolymphatic and perilymphatic pH (B) were
measured in Tg(2);Slc26a4D/D, Tg(+);Slc26a4D/+, and Tg(+);Slc26a4D/D mice. Numbers near the error bars represent the number of experiments.
doi:10.1371/journal.pgen.1003641.g008
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Figure 9. Hearing tests based on auditory brain stem responses. A–C) Examples of recordings of auditory brain stem responses to tone
bursts of 16 kHz at amplitudes between 0 and 90 dB-SPL that were presented to Tg(+);Slc26a4+/+ mice at P35 (A), Tg(2);Slc26a4D/D mice at P35 (B),
and Tg(+);Slc26a4D/D mice at P35 (C). Thresholds at 15 dB-SPL are marked (thickened trace). D–L) Hearing thresholds based on auditory brain stem
responses, were determined in Tg(+);Slc26a4D/+ mice (D–F), Tg(+);Slc26a4+/+ mice (G–I), and Tg(+);Slc26a4D/D mice (J–L; highlighted in red).
Frequencies evaluated at 8 kHz (D, G, J), 16 kHz (E, H, K), and 32 kHz (F, I, L). The combined ranges of normal hearing in the three mouse strains
(129S6, C57BL/6 and CBA) that contributed to the background of the mice are marked (grey rectangles). Numbers next to symbols in D–L represent
the number of mice tested.
doi:10.1371/journal.pgen.1003641.g009
Rescue of Hearing & Balance in Slc26a4 Mutant Mice
PLOS Genetics | www.plosgenetics.org 10 July 2013 | Volume 9 | Issue 7 | e1003641
Figure 10. Histology and pendrin expression in the vestibular labyrinth. Staining in all images consisted of immunocytochemistry of
pendrin (Pds #1 antibody; red) and F-actin (green) and of nucleic acids (blue), the latter with the exception of images B and F. Images provide
comparison of cryosections (A, C–D) and whole-mounted specimens (B) from Tg(+);Slc26a4D/D to cryosections (E, G–H) and whole-mounted
specimens (F) from Tg(2);Slc26a4D/+ mice. Whole-mounted specimens were imaged by detecting fluorescence in 25 optical sections that were
recorded in 1 mm intervals and projected into a single plane. The number of pairs of mice represented by these images are 2 for image A & E, 1 for B
& F, 2 for C & G, and 2 for D & H with 3 sections being evaluated per animal. HC, vestibular hair cells; TC, transitional cells; M, melanocytes. Additional
images using an alternative anti-pendrin antibody (Pds #2) and alternative positive controls (Tg(+);Slc26a4D/+ mice) are provided in the Supplement
(Fig. S2).
doi:10.1371/journal.pgen.1003641.g010
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of the membranous labyrinth enlargement in Slc26a4D/Dmice, and
that the complex inner ear pathology found in Slc26a4D/D mice is
largely a consequence of the enlargement during embryonic
development. This hypothesis was based on the studies in
Slc26a4D/D mice that revealed that the enlargement is a key event
on the path toward organ failure resulting in deafness and
vestibular dysfunction [12,13,18] and on studies in Foxi12/2 mice
that lack pendrin expression in the endolymphatic sac, develop an
enlargement of the inner ear, but express pendrin in the cochlea
and the vestibular labyrinth [19].
To test our hypothesis, we generated a transgenic mouse,
Tg(B1-hPDS), which expresses human SLC26A4 (previously named
PDS) controlled by the promoter of ATP1V1B1 [15]. The ability of
the promoter of ATP1V1B1 to control gene expression had
previously been evaluated in a transgenic mouse that expresses
eGFP controlled by the promoter of ATP6V1B1 [16,20].
Expression of eGFP had been found in this mouse in intercalated
cells of the renal collecting duct, and in narrow and clear cells of
the epididymal epithelium of adult mice [16]. We found
expression of eGFP in the embryonic kidney and in mitochon-
Figure 11. Otoconia. A–C) Microdissected maculae utriculi from a Tg(2);Slc26a4D/D, Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice. The macula utriculi
have been marked (red dashed line) and a single otoconium is indicated (red arrow head). D–F) Isolated otoconia from Tg(2);Slc26a4D/D,
Tg(+);Slc26a4D/D and Tg(+);Slc26a4D/+ mice. Note that images D, E.1, E.2, F.1 and F.2 are presented at the same scale. Mega-otoconia were found
only in Tg(2);Slc26a4D/D mice. Tg(+);Slc26a4D/D mice contained a mixture of larger and smaller otoconia, some of which showed a concentric pattern
(E.1, E.2 and E.3) that was similar to the mixture found in Tg(2);Slc26a4D/+ mice (F.1, F.2 and F.3).
doi:10.1371/journal.pgen.1003641.g011
Rescue of Hearing & Balance in Slc26a4 Mutant Mice
PLOS Genetics | www.plosgenetics.org 12 July 2013 | Volume 9 | Issue 7 | e1003641
dria-rich cells of the endolymphatic sac but not in the cochlea or
the vestibular labyrinth (Fig. 3). Expression in mitochondria-rich
cells of the endolymphatic sac was expected since these cells are
members of the FORE family (forkhead related) of cells. FORE
cells express FOXI1, which drives the expression of Atp6v1b1 and
Slc26a4 [21,22,23]. Consistently, mitochondria-rich cells of the
endolymphatic sac express the mRNAs Atp6v1b1 and Slc26a4
[24,25] and the corresponding proteins, the B1-subunit of the
vH+ATPase and pendrin [11,23]. The onset of expression of
Atp6v1b1 in the endolymphatic sac is at E11.5, which is similar to
the onset of pendrin [13,26]. Thus, it was likely that the transgene
Tg(B1-hPDS) would drive a timely expression of pendrin in
mitochondria-rich cells of the endolymphatic sac.
Although FOXI1 drives the expression of Atp6v1b1 and Slc26a4
in FORE cells such as the mitochondria-rich cells of the
endolymphatic sac, the expression of Atp6v1b1 and Slc26a4 is not
limited to FORE cells. Indeed, Slc26a4 is expressed in the inner
ear in spiral prominence and outer sulcus epithelial cells as well as
in spindle-shaped cells of the cochlea and in transitional cells of the
vestibular labyrinth, none of which are FORE cells [11,12].
Further, Atp6v1b1 expression has been found in the spiral limbus of
the cochlea, which does not contain FORE cells [25,26]. The
expression of Atp6v1b1 in the cochlea provided the possibility that
the transgene would drive an ectopic expression of pendrin in the
spiral limbus. Our studies of eGFP expression (Fig. 3) and of
pendrin expression by Western blotting (Fig. 4) and immunocy-
tochemistry of whole-mounted specimens and sections using two
different anti-pendrin antibodies (Pds #1 and Pds #2, Fig. 7 and
S1) revealed no detectable expression in the cochlea or vestibular
labyrinth of Tg(+);Slc26a4D/D mice. The observed absence of
pendrin expression in the vestibular labyrinth of Tg(+);Slc26a4D/D
mice (Fig. 10 and S2) is consistent with the reported lack of
Atp6v1b1 expression in the vestibular labyrinth based on detection
by in situ hybridization [25,26] and by quantitative RT-PCR
(Fig. 2B and F), which is a more sensitive technique. The
observation that human SLC26A4 mRNA but no pendrin nor
eGFP protein was detected in the cochlea or the vestibular
labyrinth suggests the presence of strong translational regulation
[27]. Taken together, our data demonstrate that we have
generated a mouse that expresses pendrin in the endolymphatic
sac but not in the cochlea or the vestibular labyrinth, although we
cannot completely rule out that low levels of pendrin protein
expression escaped our detection. Such low pendrin expression is
unlikely the reason for the restored endolymphatic volume, since
pendrin expression in the cochlea and vestibular labyrinth of
Foxi2/2 mice, which lack pendrin expression in the endolymphatic
sac, did not prevent endolymphatic enlargement [19] and since
mice that express a mutant pendrin protein that supports anion
exchange at a reduced rate are deaf, develop mega-otoconia and
are balance impaired [28]. Moreover, hypomorphic mutant alleles
of SLC26A4 show no difference in the resulting auditory phenotype
from that of functional null alleles in patients with Pendred
syndrome [29], indicating that small amounts of pendrin activity
are insufficient to rescue hearing in humans.
Measurements of the endocochlear potential and pH revealed
that the introduction of the transgene, which rescued normal
endolymph volume, also rescued the loss of the normal endoco-
chlear potential and the loss of the normal endolymphatic pH
homeostasis (Fig. 8). It appears that the Cl2/HCO3
2 exchanger
pendrin, which is normally expressed in the apical membranes of
spiral prominence and outer sulcus epithelial cells, is not the sole
mechanism responsible for the alkaline pH of endolymph in a
normally developed cochlea. A similar conclusion can be drawn
based on measurements in the doxycycline-inducible Slc26a4
mouse model where termination of pendrin expression at P6 led to
the development of a nearly normal endocochlear potential and of
a nearly normal alkaline pH [30]. We hypothesize that the
epithelial barrier enclosing endolymph is permeable to H+, OH2
and HCO3
2 and that the pH of endolymph follows the
endocochlear potential.
Figure 12. Balance tests. Tests were based on the ability of Tg(+);Slc26a4D/+, Tg(+);Slc26a4D/D, Tg(2);Slc26a4D/+, Tg(2);Slc26a4D/D mice to balance
on a rotating rod that was accelerated from 4 to 40 rpm over 60 s. Numbers near the symbols indicate the number of mice evaluated.
doi:10.1371/journal.pgen.1003641.g012
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Hearing and balance tests in Tg(+);Slc26a4D/D mice revealed
normal sensory function (Fig. 9 and 12). The observation that
hearing thresholds at 32 kHz had some variability in
Tg(+);Slc26a4D/D mice and that some Tg(+);Slc26a4D/D mice
developed progressive high-frequency hearing loss is most likely
a function of the genetic background. Tg(+);Slc26a4D/D were
generated in a F2 generation from Slc26a4D/D mice that were
maintained isogenic in the 129S6 background and Tg(+);Slc26a4D/
D mice that were recently generated in a mixed background of
C57BL/6 and CBA. DNA from the three background strains,
129S6, C57BL/6 and CBA, which differ in their hearing
thresholds, are expected to comprise variable amounts of the
genomes of individual mice. Hearing thresholds for 1 to 3 month-
old 129S6, C57BL/6 and CBA mice range between 20–35 dB-
SPL at 8 kHz, 10–28 dB-SPL at 16 kHz and 20–50 dB-SPL at
32 Hz [18,31,32,33,34,35]. In general, 129S6, C57BL/6 and
CBA mice have similar thresholds at 8 kHz, whereas at 16 and
32 kHz CBA mice have lower thresholds than 129S6 and C57BL/
6 mice. Thus, the greater variability in hearing thresholds that was
observed at 32 kHz particularly in Tg(+);Slc26a4D/D may be due to
a variability in the mixture of these background strains.
Our observation that normal hearing developed in the absence
of pendrin expression in the cochlea in combination with the
published finding that normal hearing was maintained when
pendrin expression was terminated after completed development
[30], could suggest that pendrin in the cochlea has no physiologic
significance beyond the developmental phase. However, it is also
conceivable that pendrin-mediated HCO3
2 secretion provides a
buffer that stabilizes the pH in the lateral wall tissues as well as in
endolymph, and that this buffering is important during stress
situations associated with normal life. Pendrin expression may
indeed be important for the maintenance of hearing into advanced
age.
In summary, we demonstrated that restoration of pendrin to the
endolymphatic sac is sufficient to restore normal inner ear
function. This implies that pendrin in the endolymphatic sac is
more important for the development of normal hearing than
pendrin expression in the cochlea and more important for the
development of normal balance than pendrin expression in the
vestibular labyrinth. This finding, in conjunction with our previous
report that pendrin expression is required for embryonic
development but not for the maintenance of hearing, opens the
prospect that a spatially and temporally limited therapy will restore
normal hearing in human patients carrying a variety of mutations
of SLC26A4.
Methods
Ethics statement
All animal experiments and procedures at Kansas State
University were performed according to protocols approved by
the Animal Care and Use Committees at Kansas State University
(IACUC#: 2961). All animal procedures at Sorbonne University
Paris Cite´ were performed according to protocols approved by the
ethics committee from University Pierre et Marie Curie, and were
performed in accordance with the Guide for the Care and Use of
Laboratory Animals (NIH publication No. 93-23, revised 1985).
Generation of Tg(B1-hPDS)Tg/+;Slc26a4+/+ transgenic
mice
Human SLC26A4 cDNA was ligated into a pBluescript vector
that contained 6.9 kbp of the human ATP6V1B1 promoter
[16,20]. An SV40 late region polyadenylation signal was cloned
downstream of the SLC26A4 cDNA. The transgene Tg(B1-hPDS)
included the 59-flanking region of the ATP6V1B1 gene extending
to but excluding the endogenous translational start codon, the
human SLC26A4 cDNA, with its own translational start site, and
the SV40 late region polyadenylation signal. The integrity of the
transgene was confirmed by restriction digest and bidirectional
sequencing of ligation sites. In preparation for injection, the
transgene was linearized by SalI and NotI digestion, followed by
gel purification using an electroelution method and then
concentrated using ElutipD columns (Whatman). The transgene
was then further concentrated by ethanol precipitation and
resuspended in low EDTA injection buffer (10 mM Tris with
0.1 mM EDTA). Tg(B1-hPDS) transgenic mice were created by
the University of Utah transgenic mouse core facility using
standard procedures [16,20]. Genotyping revealed that 63 pups
were positive for transgene integration. One founder, which
transmitted the transgene in a Mendelian fashion, was crossed
with wild-type C57BL/66 CBA F1 mice to establish a colony.
Three Tg(B1-hPDS);Slc26a4+/+ transgenic mice were shipped to
Kansas State University in Manhattan, Kansas, USA.
Generation of Tg(B1-hPDS)Tg/+;Slc26a4D/D transgenic
mice
At Kansas State University, a colony of Tg(B1-hPDS)Tg/+;
Slc26a4D/D mice was established. Colony management was
supported by software (Litter tracker, written in Microsoft Visual
Basic and Excel 2010 by P.W.) Tg(B1-hPDS)Tg/+;Slc26a4+/+ mice
were crossed with Slc26a4D/D mice to generate Tg(B1-hPDS)Tg/+;
Slc26a4D/+ mice. Matings of Tg(B1-hPDS)Tg/+;Slc26a4D/+ mice
generated 28 Tg(B1-hPDS)Tg/+;Slc26a4+/+, 58 Tg(B1-hPDS)Tg/+;
Slc26a4D/+ and 39 Tg(B1-hPDS)Tg/+;Slc26a4D/D mice in a near
Mendelian ratio of 1 : 2 : 1 with a 75% rate of transmission for the
transgene (based on 169 pups).
Genotyping
Mice were genotyped for Slc26a4+ and Slc26a4D alleles by PCR
using established primers [14] and for the transgene Tg(B1-hPDS)
(Transnetyx, Cordova, TN). Primers for the transgene were
designed to amplify a 345 bp PCR-product spanning the hPDS
cDNA and the SV40 polyadenylation signal sequence (left primer:
59-aga ggg tca agg ttc cat ttt ag-39; right primer: 59-caa acc aca act
aga atg cag tg-39) [15].
Isolation of embryonic tissues
Time-pregnant dams were deeply anesthetized with 4% tri-
bromo-ethanol (0.014 ml/g body weight, i.p.) and embryos were
harvested by laparotomy. Dams and embryos were sacrificed by
decapitation. Gestational age was counted from the day when the
vaginal plug was detected. This day was set to embryonic (E) day
0.5. Gestational age, however, was verified by evaluating gross
morphological features including limbs, digits and the appearance
of the pinna and auditory meatus [36,37].
Isolation of tissues from postnatal mice
The age of mice was counted from the day of birth, which was
set to postnatal (P) day 0. Postnatal mice were deeply anesthetized
with 4% tri-bromo-ethanol (0.014 ml/g body weight, i.p.) and
sacrificed by decapitation or cardiac perfusion with fixative.
Quantitative RT-PCR
Quantitative RT-PCR was performed on total RNA [17]. Total
RNA was isolated from tissues obtained by microdissection from
Tg(2);Slc26a4D/+ and Tg(+);Slc26a4D/D mice and subjected to
quantitative RT-PCR using gene-specific primers for 18S rRNA
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as well as for mRNA coding for the a-subunit of the mouse Na+/
K+ ATPase Atp1a1, the B1-subunit of the mouse vH+ATPase
Atp6v1b1, mouse pendrin Slc26a4 and human pendrin SLC26A4,
which was introduced via the transgene.
Postnatal mice were genotyped by PCR prior to tissue
collection. Embryonic Tg(2);Slc26a4D/+ mice were generated by
mating Tg(2);Slc26a4D/D dams and Tg(2);Slc26a4+/+ sires, which
yielded 100% of the desired genotype. Embryonic Tg(+);Slc26a4D/D
mice were generated by mating Tg(+);Slc26a4D/D dams and sires,
which yielded Tg(+);Slc26a4D/D and Tg(2);Slc26a4D/D mice in a
ratio of 3 : 1. Since embryonic mice could not be genotyped prior to
tissue collection, the desired Tg(+);Slc26a4D/D mice among
Tg(2);Slc26a4D/D mice were initially identified by visual inspection
of the size of the endolymphatic sac and the presence of ‘glittering’
otoconia, This phenotypic identification was subsequently con-
firmed by the presence of human pendrin SLC26A4 transgene by
RT-PCR.
Tissues were obtained by microdissection. Endolymphatic sacs
(8–10 endolymphatic sacs from 4–5 animals per sample) were
obtained from mice at age E17.5. Cochlear ducts (4 cochlear ducts
from 2 animals per sample and 2 cochlear ducts from 1 animal per
sample) were obtained from mice at ages E17.5 and P2,
respectively. Vestibular labyrinths (6 vestibular labyrinths from 3
animals per sample) were obtained from mice at age P8. Total
RNA was isolated from microdissected tissues (RNeasy micro kit,
Qiagen, Valencia, CA, USA), treated with DNAse (RNeasy micro
kit), combined with RNA storage solution (Applied Biosystems/
Ambion, Austin, TX), adjusted to a concentration of 10 ng/ml,
and stored at 280uC.
Quantity and quality of total RNA were evaluated by
microfluidic electrophoresis (BioAnalyzer, Agilent, Santa Clara,
CA), by microliter absorption photometry (Nanodrop, Wilming-
ton, DE) and by quantitative RT-PCR of 18S rRNA. RNA
samples were accepted for quantitative RT-PCR only when they
were free of contamination and excellent RNA quality. RNA
quality was quantified by the RNA integrity number (RIN) on a
scale from 0 (worst) to 10 (best) (BioAnalyzer, Agilent). RIN
numbers for total RNA isolated from E17.5 endolymphatic sac
and cochlea were 8.260.3 (n = 3) and 9.260.1 (n = 10).
Chemicals were assembled with the assistance of an automatic
pipetting station (Biomek NXp, Beckman Coulter, Fullerton, CA)
with hardware modifications and software programming by P.W.
Quantitative RT-PCR reactions were carried out in 96-well plates
with each well containing ,10 ng of total RNA, gene specific
primers, and an enzyme mix containing reverse transcriptase and
DNA polymerase (iScript, BioRad, Hercules, CA) in a total
volume of 25 ml. Reverse transcription was performed for 10 min
at 50uC and terminated by heating to 95uC for 5 min
(OneStepPlus, Applied Biosystems, Foster City, CA). PCR
consisted of 40 cycles of 10 s melting at 95uC, 30 s annealing
and elongation at 58uC, and 15 s hot-measurement at 78uC
(OneStepPlus, Applied Biosystems).
Left and right primers (exon, product size) were for 18S 59-gag
gtt cga aga cga tca ga-39 and 59-tcg ctc cac caa cta aga ac-39
(316 bp), for Atp1a1 59-tgc ccg cct caa cat tcc-39 (exon 14) and 59-
gac aca tca gag cca aca atc c-39 (exon 16, 291 bp), for Atp6v1b1 59-
tga ccc gaa act aca tca cc-39 (exon 1) and 59-gcc aga gcc att gaa aat
cc-39 (exon 5, 305 bp), for mouse Slc26a4 59-tct gat gga ggc aga gat
ga-39 (exon 20) and 59-ggc cag cct aac aga gac ag-39 (exon 21,
430 bp), and for human SLC26A4 were 59-tcc caa agt gcc aat cca
ta-39 and 59-aca tca agt tct tct tcc gtc ag-39 (360 bp). Primer pairs
for Atp1a1, Atp6v1b1, mouse Slc26a4 spanned introns to prevent
amplification of genomic DNA. Primer pairs for mouse Slc26a4
detected the Slc26a4+ allele as well as the Slc26a4D allele that is
lacking exon 8 [14]. Left and right primers for mouse Slc26a4
differed by 7 and 10 nucleotides from the corresponding human
sequence and left and right primers for human SLC26A4 differed
in 4 and 6 nucleotides from the corresponding mouse sequence,
thereby maximizing species-specific amplification. Since the
human transgene did not contain introns, some reactions were
carried out without reverse transcriptase to determine whether
products of SLC26A4 originated from cDNA rather than from
genomic DNA. These experiments revealed no evidence for
significant amplification of genomic DNA. Amplification of a
single product of the appropriate size was verified by microfluidic
electrophoresis (BioAnalyzer, Agilent).
The number of template molecules (cDNATemplate) was estimated
according to
cDNATemplate molecules½ 
~
6:02:1023 molecules½  : ProductThreshold g½  : mol½  : bp½ 
mol½  : ProductSize bp½  : Weightbp g½  : mol½  : Efficiency C^t
where 6.0261023 molecules/mol represents Avogadro’s number,
ProductThreshold is the weight of the PCR-product at threshold
(0.4961029 g) that was obtained from calibration experiments,
ProductSize is the size of the product in base pairs (bp), Weightbp is
average weight of one bp (660 g/mol), Efficiency is the PCR-
efficiency obtained from the slope of the log-linear phase of the
growth curve [38] and Ct is the cycle at which the fluorescence of
the product molecules reaches a common threshold chosen in the
middle of the log-linear part of the growth curve.
Paint-fill
Bisected heads of embryos age E15.5 were fixed overnight in
Bodian’s fixative, contained (vol/vol) 75% ethanol, 5% acetic acid,
and 5% formalin in water. Heads were then dehydrated overnight
in 100% ethanol and cleared in methyl-salicylate [39,40]. The
membranous labyrinth was injected via the lateral wall of the basal
turn of the cochlea and via the endolymphatic sac with diluted
paint (Liquid Paper, Newell Rubbermaid, Atlanta, GA, 0.1–0.2%
in methyl-salicylate) using a fine glass-electrode, a manipulator
(NM-151 Narishige) and a micrometer-driven oil-filled micro-
injector (CellTram Vario, Eppendorf, Hamburg, Germany). For
each genotype, at least three inner ears were injected.
Direct fluorescence of eGFP
Whole mounts of fresh cochlear ducts, endolymphatic sacs and
slices of kidney were prepared from E15.5 Tg(B1-eGFP) mice and
visualized with a fluorescence microscope (AxioScope, Carl Zeiss
Go¨ttingen).
Western blotting
Crude membrane preparations of the inner ear. Soft
tissues from 8 cochleae and 8 vestibular labyrinths devoid of
endolymphatic sacs from adult mice were collected by microdis-
section in Cl2-free solution and pooled and homogenized in
500 ml Tris-sucrose buffer. Cl2-free solution contained (mM) 150
Na-gluconate, 1.6 K2HPO4, 0.4 KH2PO4, 4 Ca-gluconate2, 1
MgSO4 and 5 glucose, pH 7.4. Tris-sucrose buffer contained
(mM) 250 sucrose, 50 Tris-HCl, 5 EDTA, pH=7.4, and
proteinase inhibitor cocktail (Cat# PI-87786 Fisher, Pittsburgh,
PA). Homogenization involved a pestle/1.5 ml Eppendorf vial and
a Potter-Elvehjem tissue grinder (3 strokes at 1,250 rpm; Cat#
K885512-0020, Fisher). Nuclei and debris were sedimented by
centrifugation (6 min, 600 g, 4uC, Micromax RF, International
equipment, Needham Heights, MA) and the supernatant contain-
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ing membranes was collected. Pellets were washed 36with 100 ml
Tris-sucrose buffer. Supernatants were pooled and membranes
were pelleted by centrifugation (1 hr, 21,000 g, 4uC, Micromax
RF). Membranes were suspended in 30 ml Tris-sucrose buffer and
protein content was quantified (BCA assay, Cat# 23227, Fisher;
Absorption photometer, Nanodrop).
Crude membrane preparations of kidneys. Kidneys
(,1 g wet weight) were sliced, frozen in liquid N2, pulverized,
transferred into 8 ml Tris-sucrose buffer and homogenized.
Homogenization involved pestles fitting 1.5 ml Eppendorf vials
and the Potter-Elvehjem tissue grinder (3 strokes at 1,250 rpm).
Nuclei and debris were sedimented by centrifugation (6 min,
600 g, 4uC, Micromax RF) and the supernatant containing
membranes was collected. Pellets were washed 36 with 2 ml
Tris-sucrose buffer. Supernatants were pooled and membranes
were pelleted by centrifugation (1 hr, 21,000 g, 4uC, Micromax
RF). Membranes were suspended in 200 ml Tris-sucrose buffer
and protein content was quantified (BCA assay).
Gel-electrophoresis, blotting and protein
detection. Crude membranes were solubilized, denatured and
reduced for 1 hr at 37uC in LDS sample buffer (Cat#: NP0007;
Invitrogen) supplemented with 50 mM DTT. Proteins were
resolved by gel-electrophoresis (4–12% Bis-Tris gels (Cat#:
NP0326, Invitrogen) using a MOPS-SDS running buffer supple-
mented with an antioxidant (Cat#: NP0005, Invitrogen) and
transferred onto PVDF membranes (BioRad, 3 hrs at 30 V).
PVDF membranes were blocked for 1 hr at RT in TBST solution
containing 3% BSA. TBST solution contained 20 mM Tris-base,
68 mM NaCl, and 1% Tween-20. Blocked PVDF membranes
were incubated overnight at 4uC with primary antibody in TBST
solution with 3% BSA. Primary antibodies were a rabbit anti-
pendrin antibody (Pds #2; 1:200) and a polyclonal rabbit anti-
mouse b-actin antibody (1: 1,000; Cat#: A2066, Sigma-Aldrich).
Pds #2 was raised against the last 15 amino acids of the C-
terminal of mouse pendrin [30]. Human pendrin differs in only 1
of these 15 amino acids. PVDF membranes were washed 563 min
in TBST solution and then incubated for 1 hr at RT with the
secondary antibody, goat anti-rabbit poly-HRP (Cat#: PI32260,
Fisher) diluted in TBST solution with 3% BSA. The dilution of the
secondary antibody was 1:2,500 for labeling the Pds #2 antibody
and 1:10,000 for labeling the b-actin antibody. The membranes
were washed 365 min in TBST solution. HRP was detected by
chemiluminescence (SuperSignal Femto, Cat# PI34095, Fisher).
The signal was integrated over 2–5 min by cooled CCD camera
(ImageStation 4000R, Kodak).
Immunocytochemistry
Fixation. Isolated tissues from embryonic mice were fixed by
submersion in PBS-formaldehyde solution at 4uC. PBS-formalde-
hyde solution consisted of 4% formaldehyde (Electron Microscopy
Sciences, Hatfield PA) in a solution that contained (in mM) 137
NaCl, 2.7 KCl, 10.1 Na2HPO4, 1.8 KH2PO4. Tissues from
postnatal animals were fixed by cardiac perfusion followed by
perilymphatic perfusion. Cardiac perfusion was initiated with Cl2-
free solution (6 ml, 1 min) and followed by Cl2-free solution with
4% formaldehyde (12 ml, 2 min). Perilymphatic perfusion con-
sisted of an infusion of Cl2-free solution with 4% formaldehyde
(25 ml, 5 min) through the round and oval window of the cochlea.
Cryosections. Fixed temporal bones were decalcified 18–
24 h in 10% EDTA, processed through a sucrose gradient and
infiltrated with polyethylene glycol. Mid-modiolar cryosections
(12 mm, CM3050S, Leica, Nussloch, Germany) were blocked in
PBS-TX (137 mM NaCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4,
2.7 mM KCl, pH 7.4 with 0.15% Triton X 100) and 5% bovine
serum albumin. Slides were incubated overnight at 4uC with
primary antibody in PBS-TX with 2.5% BSA. Primary antibodies
were two rabbit anti-pendrin antibodies (Pds #1; 1:200; a kind gift
from Dr. Søren Nielsen, University of Aarhus, Denmark and Pds
#2, 1:1,000) and a polyclonal FITC-conjugated goat anti-eGFP
antibody (Cat#: GTX26662, GeneTex, San Antonio, TX). Pds
#1 was raised against the last 22 amino acids of the C-terminal of
mouse pendrin. Human pendrin differs in 6 of these 22 amino
acids [13,41]. Slides were washed with PBS-TX and, where
appropriate, incubated for 1 h at RT with secondary antibody
(1:1,000, goat anti-rabbit Alexa 594, Invitrogen, Carlsbad, CA).
After washing with PBS-TX, sections, where appropriate, were
stained with phalloidin 488 (1:40; Invitrogen) to mark F-actin and
DAPI (1:1,000; Invitrogen) to mark nuclei, washed again and
cover-slipped with mounting medium (Vectashield HardSet
Mounting Medium, Vector laboratories, Burlingame, CA).
Whole-mounted specimens. Tissues were obtained by
microdissection from fixed temporal bones, washed in PBS-TX,
and blocked with 5% bovine serum albumin in PBS-TX. Tissues
were incubated overnight at 4uC with primary antibodies in PBS-
TX with 2.5% BSA. Primary antibodies were a rabbit anti-
pendrin antibody (Pds #1; 1:200) or a polyclonal FITC-
conjugated goat anti-eGFP antibody (GeneTex). Slides were
washed with PBS-TX and, where appropriate, incubated for 1 h
at RT with secondary antibody (1:1,000, goat anti-rabbit Alexa
594, Invitrogen). After washing with PBS-TX, tissues were stained
with phalloidin 488 or phalloidin 594 (1:40; Invitrogen) and DAPI
(1:1000; Invitrogen), washed again and cover-slipped with
mounting medium (VectaShield HardSet Mounting Medium,
Vector laboratories, Burlingame, CA).
Confocal microscopy. Immunocytochemistry of cryosec-
tions and whole-mounted specimens were viewed by confocal
microscopy (LSM 510 Meta, Carl Zeiss, Go¨ttingen, Germany).
Laser scanning bright-field images were collected to aid orienta-
tion.
Endocochlear potential and pH difference between
endolymph and perilymph
Mice were anesthetized with 4% tri-bromo-ethanol for in situ
measurements of the endocochlear potential and pH with double-
barreled microelectrodes. Measurements were made in the basal
turn of the cochlea by a round-window approach through the
basilar membrane of the first turn of the cochlea [18,42]. The
surgical cavity was covered with liquid Sylgard 184 (Dow Corning)
to limit the loss of tissue CO2 into ambient air.
Double-barreled glass microelectrodes were pulled (micropi-
pette puller PD-5; Narishige) from filament-containing glass tubing
(1B100F-4; World Precision Instruments) and baked at 180uC for
2 h to ensure dryness. One barrel was silanized by a 30 s exposure
to 0.008 ml dimethyldichlorosilane (40136; Fluka). After silaniza-
tion, microelectrodes were baked again at 180uC for 3 h and tips
were broken to a final O.D. of ,3 mm. The reference barrel was
filled with 150 mM KCl and the ion-selective barrel was filled at
the tip with liquid ion exchanger (Hydrogen ionophore II -
Cocktail A, 95297; Fluka) and back-filled with buffer solution
(500 mM KCl, 20 mM HEPES, pH 7.4).
Each barrel of the double-barreled microelectrode was
connected via a Ag/AgCl2 electrode to an electrometer (FD223,
World Precision Instruments). A flowing KCl electrode (1 M KCl
in 0.2% agar) was inserted under the skin of the animal to serve as
ground electrode. Data were recorded in analog (BD12E Flatbed
recorder, Kipp & Zonen, Delft, The Netherlands) and digital form
(DIGIDATA 1322A and AxoScope 10, Axon Instruments, Union
City, CA). pH electrodes were calibrated in situ at 37uC using three
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calibration solutions with different pH values. Calibration
solutions contained (in mM): pH 6: 130 NaCl, 20 MES; pH 7:
130 NaCl, 20 HEPES; and pH 8: 130 NaCl, 20 HEPES. pH-
sensitive electrodes had a slope of 56.9 6 0.3 mV/pH unit
(n = 11).
Hearing tests
Mice were deeply anesthetized with a mixture of dexmedeto-
midine and ketamine (0.375 mg/Kg body weight dexmedetomi-
dine and 56 mg/kg body weight ketamine; i.p.) and placed on a
thermal pad to maintain normal body temperature. The mastoid,
vertex and ventral neck region of the animal were connected via
sub-dermal platinum needle electrodes (F-E2, Astro Med, Rhode
Island, RI) and short (31 cm) leads to the main channel, reference
channel and ground of the preamplifier, respectively. Auditory
brainstem recordings were performed in a custom constructed,
electrically shielded and sound-attenuated chamber (inner dimen-
sions: 23 cm623 cm623 cm) using a digital data acquisition
system (BioSig32 software, RA4LI Preamplifier, RP2.1 Enhanced
Real Time Processor, PA5 Programmable Attenuator, ED1
Electrostatic Speaker Driver, Tucker-Davis Technologies, Ala-
chua, FL). Tone burst stimuli were presented (21 per sec) via a free
field electrostatic speaker (SigGen software, ES1 speaker, Tucker
Davis). Acoustic stimuli were calibrated using a 1/4 inch
condenser microphone (SigCal IRP4.2 software, Tucker Davis,
PS9200 microphone, Acoustical Interface, Belmont, CA) placed at
the location of the mouse head. Tone bursts (2 ms duration,
0.5 ms gate time; 8, 16 and 32 kHz) were presented with
alternating phase (0 and 180u). Responses, recorded over 10 ms,
were filtered (300 Hz high pass, 3000 Hz low pass and 60 Hz
notch) and 1000 recordings were averaged. Tone burst stimuli
were presented at intensities varying between 90 and 0 dB SPL in
5 dB intervals. Auditory thresholds were obtained by a visual
comparison of wave forms. After the procedure, mice were rapidly
recovered from anesthesia with atipamizole (1.875 mg/kg body
weight; i.p.).
Balance tests
Balance testing consisted of determining the time that mice
could balance on a rotating 10 rod with rotations ramping up from
4 to 40 rpm in 60 s (RotaRod, IITC Life Science, Woodland Hills,
CA). Test chambers were cushioned with bubble-foil to provide a
soft landing for mice falling off the rod.
Supporting Information
Figure S1 Histology and pendrin expression in the cochlea.
Staining in all images consisted of immunocytochemistry of
pendrin (Pds #1 antibody or Pds #2 antibody; red), F-actin (green)
and nucleic acids (blue). Images provide comparison of pendrin
expression in Tg(+);Slc26a4D/D mice (A, C, E) to positive controls
consisting of Tg(+);Slc26a4D/+ (B, D) or Tg(2);Slc26a4D/+ mice (F).
Note that both antibodies, Pds #1 and Pds #2, failed to detect
pendrin expression in Tg(+);Slc26a4D/D mice and that the staining
pattern for pendrin in positive controls was similar for both
antibodies and for both positive controls. The number of pairs of
mice represented by these images are 2 for images A & B, 1 for C
& D, and 2 for E & F with 3 sections being evaluated per animal.
K, Ko¨lliker’s organ; OS, outer sulcus; Lim, spiral limbus; IS, inner
sulcus; OC, organ of Corti; SP, spiral prominence; SV, stria
vascularis; RM, Reissner’s membrane. Compare these images to
those in Fig. 7.
(TIFF)
Figure S2 Histology and pendrin expression in the vestibular
labyrinth. Staining in all images consisted of immunocytochem-
istry of pendrin (Pds #1 antibody or Pds #2 antibody; red) and F-
actin (green) and of nucleic acids (blue). Images provide comparison
of pendrin expression in Tg(+);Slc26a4D/D mice (A,C,E,G,I,K) to
positive controls consisting of Tg(+);Slc26a4D/+ (B, F, J) or
Tg(2);Slc26a4D/+ mice (D,H,L). Note that both antibodies, Pds
#1 and Pds #2, failed to detect pendrin expression in
Tg(+);Slc26a4D/D mice and that the staining pattern for pendrin
in positive controls was similar for both antibodies and for both
positive controls. The number of pairs of mice represented by
these images are 2 for images A & B, 2 for images C & D, 1 for
images E & F, 2 for images G & H, 2 for images I & J, and 2 for
images K & L. HC, vestibular hair cells; TC, transitional cells; M,
melanocytes. Compare these images to those in Fig. 10.
(TIFF)
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